CONSENSO SOBRE CONTRACEÇÃO 2020
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Contraceção Hormonal e Intrauterina com Condições Médicas Especiais | TRANSPLANTE DE ORGÃOS SÓLIDOS | D11<br />
BIBLIOGRAFIA<br />
1. Curtis, K. M. et al. U.S. Medical Eligibility Criteria for Contraceptive Use,<br />
2016. MMWR. Recommendations and reports : Morbidity and mortality<br />
weekly report. Recommendations and reports / Centers for Disease Control<br />
65, (2016).<br />
2. Juliato, C. R. T., Stahlschmidt, P., Fernandes, A., Monteiro, I. & Bahamondes,<br />
L. A case series on the use of levonorgestrel 52 mg intrauterine<br />
system after organ transplant. Contraception 98, 252–254 (2018).<br />
3. Kim, C. R. et al. Immunologic evaluation of the endometrium with<br />
a levonorgestrel intrauterine device in solid organ transplant women<br />
and healthy controls. Contraception 94, 534–540 (2016).<br />
4. Huguelet, P. S., Sheehan, C., Spitzer, R. F. & Scott, S. Use of the<br />
levonorgestrel 52-mg intrauterine system in adolescent and young<br />
adult solid organ transplant recipients: a case series. Contraception 95,<br />
378–381 (2017).<br />
5. Paulen, M. E., Folger, S. G., Curtis, K. M. & Jamieson, D. J. Contraceptive<br />
use among solid organ transplant patients: a systematic review.<br />
Contraception 82, 102–112 (2010).<br />
6. Sridhar, A., Cwiak, C. A., Kaunitz, A. M. & Allen, R. H. Contraceptive<br />
Considerations for Women with Gastrointestinal Disorders. Digestive<br />
Diseases and Sciences 62, 54–63 (2017).<br />
111
Change language